Cytomegalovirus antibody level and mortality among community-dwelling older adults with stable cardiovascular disease.
Strandberg
Timo E
TE
Pitkala
Kaisu H
KH
Tilvis
Reijo S
RS
D000368:Aged; D000369:Aged, 80 and over; D000704:Analysis of Variance; D000914:Antibodies, Viral / Q000097:blood*; D002318:Cardiovascular Diseases / Q000097:blood / Q000150:complications* / Q000401:mortality; D002423:Cause of Death; D003587:Cytomegalovirus / Q000276:immunology*; D003586:Cytomegalovirus Infections / Q000097:blood / Q000453:epidemiology / Q000276:immunology* / Q000401:mortality*; D019317:Evidence-Based Medicine; D005260:Female; D005387:Finland / Q000453:epidemiology; D005500:Follow-Up Studies; D006801:Humans; D007124:Immunoenzyme Techniques; D007074:Immunoglobulin G / Q000097:blood; D008297:Male; D016016:Proportional Hazards Models; D011446:Prospective Studies; D012111:Residence Characteristics
D000914:Antibodies, Viral; D007074:Immunoglobulin G